These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 28012891)

  • 61. Microtubule-Stabilizing 1,2,4-Triazolo[1,5-
    Alle T; Varricchio C; Yao Y; Lucero B; Nzou G; Demuro S; Muench M; Vuong KD; Oukoloff K; Cornec AS; Francisco KR; Caffrey CR; Lee VM; Smith AB; Brancale A; Brunden KR; Ballatore C
    J Med Chem; 2023 Jan; 66(1):435-459. PubMed ID: 36534051
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Microtubule-dependent transport in neurons: steps towards an understanding of regulation, function and dysfunction.
    Guzik BW; Goldstein LS
    Curr Opin Cell Biol; 2004 Aug; 16(4):443-50. PubMed ID: 15261678
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Microtubule motors, phosphorylation and axonal transport of neurofilaments.
    Shea TB
    J Neurocytol; 2000; 29(11-12):873-87. PubMed ID: 11466476
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tubulin Cytoskeleton in Neurodegenerative Diseases-not Only Primary Tubulinopathies.
    Cyske Z; Gaffke L; Pierzynowska K; Węgrzyn G
    Cell Mol Neurobiol; 2023 Jul; 43(5):1867-1884. PubMed ID: 36352320
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structural Basis for Induction of Peripheral Neuropathy by Microtubule-Targeting Cancer Drugs.
    Smith JA; Slusher BS; Wozniak KM; Farah MH; Smiyun G; Wilson L; Feinstein S; Jordan MA
    Cancer Res; 2016 Sep; 76(17):5115-23. PubMed ID: 27488522
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
    Lipton SA; Gu Z; Nakamura T
    Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novel therapeutics based on tau/microtubule dynamics: WO2008084483.
    Alonso Adel C; Corbo CP
    Expert Opin Ther Pat; 2009 Sep; 19(9):1335-8. PubMed ID: 19555159
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ROCK inhibition in models of neurodegeneration and its potential for clinical translation.
    Koch JC; Tatenhorst L; Roser AE; Saal KA; Tönges L; Lingor P
    Pharmacol Ther; 2018 Sep; 189():1-21. PubMed ID: 29621594
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Motor neurons rely on motor proteins.
    Holzbaur EL
    Trends Cell Biol; 2004 May; 14(5):233-40. PubMed ID: 15130579
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quantitative analysis of microtubule transport in growing nerve processes.
    Ma Y; Shakiryanova D; Vardya I; Popov SV
    Curr Biol; 2004 Apr; 14(8):725-30. PubMed ID: 15084289
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of Microtubule Stabilization by Epothilone B Depend on the Type and Age of Neurons.
    Jang EH; Sim A; Im SK; Hur EM
    Neural Plast; 2016; 2016():5056418. PubMed ID: 27872763
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-Microtubule Drugs.
    Florian S; Mitchison TJ
    Methods Mol Biol; 2016; 1413():403-21. PubMed ID: 27193863
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Developing nanotherapies for neurodegenerative diseases: ORMOSIL and its potential in axonal transport.
    Gunawardena S
    Ther Deliv; 2012 Oct; 3(10):1189-98. PubMed ID: 23116011
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies.
    Venkatramani A; Panda D
    Int J Biol Macromol; 2019 Jul; 133():473-483. PubMed ID: 31004638
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Syntaphilin mediates axonal growth and synaptic changes through regulation of mitochondrial transport: a potential pharmacological target for neurodegenerative diseases.
    Wu QY; Liu HL; Wang HY; Hu KB; Liao P; Li S; Long ZY; Lu XM; Wang YT
    J Drug Target; 2023 Aug; 31(7):685-692. PubMed ID: 37358358
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 'Axogenic' and 'somagenic' neurodegenerative diseases: definitions and therapeutic implications.
    Schwartz M; Yoles E; Levin LA
    Mol Med Today; 1999 Nov; 5(11):470-3. PubMed ID: 10529787
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Microtubule stabilization promoted axonal regeneration and functional recovery after spinal root avulsion.
    Li H; Wu W
    Eur J Neurosci; 2017 Jul; 46(1):1650-1662. PubMed ID: 28444817
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A Growth-Fragmentation Approach for Modeling Microtubule Dynamic Instability.
    Honoré S; Hubert F; Tournus M; White D
    Bull Math Biol; 2019 Mar; 81(3):722-758. PubMed ID: 30484040
    [TBL] [Abstract][Full Text] [Related]  

  • 80. To the end of the line: Axonal mRNA transport and local translation in health and neurodegenerative disease.
    Costa CJ; Willis DE
    Dev Neurobiol; 2018 Mar; 78(3):209-220. PubMed ID: 29115051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.